eIF3B Monoclonal Antibody


eIF3B Monoclonal Antibody

  • Size: 100ul
  • Application: WB, FCM, IHC-P, IF(ICC)
  • Reactivity: Human, Mouse, Rat
  • Predicted Reactivity:

  • Datasheet      Tech Support


Catalog# bsm-54710R

Size:100ul Datasheet


 SizePrice
 100ul ₹ 50828

Contact Us


IMAGES






PRODUCT DETAILS






SPECIFICATIONS

PRODUCT NAME

eIF3B Monoclonal Antibody

CONJUGATION

Unconjugated

HOST

Rabbit

SOURCE

Synthetic Peptide within N terminal human eIF3B.

IMMUNOGEN RANGE

CLONALITY

Monoclonal

ISOTYPE

IgG

CONCENTRATION

1ug/ul

PURIFICATION

Purified by Protein A.

STORAGE BUFFER

Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide.

STORAGE CONDITION

Store at -20°C for 12 months..


TARGET

GENE ID

8662

SUBCELLULAR LOCATION

Cytoplasm

SYNONYMS

eIF-3-eta antibody, eIF3 eta antibody, eIF3 p110 antibody, eIF3 p116 antibody, EIF3-ETA antibody, EIF3-P110 antibody, EIF3-P116 antibody, eIF3b antibody, EIF3B_HUMAN antibody, EIF3S9 antibody, EIF3S9, formerly antibody, Eukaryotic translation initiation factor 3, subunit B antibody, Eukaryotic translation initiation factor 3 subunit 9 antibody, eukaryotic translation initiation factor 3 subunit 9 eta antibody, Eukaryotic translation initiation factor 3 subunit B antibody, eukaryotic translation initiation factor 3, subunit 9 (eta, 116kD) antibody, eukaryotic translation initiation factor 3, subunit 9 eta, 116kDa antibody, eukaryotic translation initiation factor 3, subunit 9, formerly antibody, hPrt1 antibody, Protein synthesis defective at 36 degrees celsius 1, S. cerevisiae, homolog of antibody, PRT1 antibody, Prt1 homolog antibody

BACKGROUND

eIF3b expression relates to human bladder and prostate cancer prognosis, is required for tumor growth, and thus a candidate therapeutic target.The initiation of protein synthesis in eukaryotic cells is regulated by interactions between protein initiation factors and RNA molecules. Association of eIF3 proteins with the 40S ribosomal subunit stabilizes eIF2-GTP-Met-tRNAiMet complex association and mRNA binding, and promotes dissociation of 80S ribosomes into 40S and 60S subunits, thereby promoting the assembly of the pre-initiation complex. Overexpression of eIF3 proteins is common in several cancers, suggesting a role for eIF3 proteins in tumorigenesis.

APPLICATION DILUTION

WB(1:300-1000), FCM(1:20-100), IHC-P(1:200-400), IF(ICC)(1:50-200)












CITATION







Have you cited this product in a publication?
Let us know so we can reference it here.

Contact Us










We're here to help


Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.


Contact Tech Support







High Quality Guaranteed Product


Our products such as Elisa, Antibodies, Proteins, Peptides are covered by Biolinkk quality warranty and will work as described in datasheet, a free replacement or money back is guaranteed if does not perform according to datasheet.


Learn More